DWS Health and Wellness C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
DWS Health and Wellness Fund - Class C SUHCX
- NAV / 1-Day Return 22.88 / −0.13 %
- Total Assets 257.3M
-
Adj. Expense Ratio
2.090%
- Expense Ratio 2.090%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Health
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 2%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 10:09 PM GMT+0
Morningstar’s Analysis SUHCX
Will SUHCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.70 | 33M | Healthcare |
Johnson & Johnson | 6.32 | 16M | Healthcare |
UnitedHealth Group Inc | 5.51 | 14M | Healthcare |
AbbVie Inc | 4.97 | 13M | Healthcare |
Merck & Co Inc | 4.82 | 12M | Healthcare |
Thermo Fisher Scientific Inc | 3.62 | 9M | Healthcare |
AstraZeneca PLC | 3.12 | 8M | Healthcare |
Amgen Inc | 2.95 | 8M | Healthcare |
Novartis AG ADR | 2.95 | 8M | Healthcare |
Abbott Laboratories | 2.65 | 7M | Healthcare |